Concepedia

Jasleen K. Randhawa

JK

9

Publications

347

Citations

9

H-Index

2014

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Princess Margaret Cancer Centre

Presbyterian Hospital

Fred Hutch Cancer Center

Ottawa Hospital

Jasleen K. Randhawa is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, hematology, and medicine.

Top concepts

Publications per year

2014–2023

9

Publications

9

Results of a Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients (Pts) with Activating FLT3 Mutations

Jasleen K. Randhawa, Hagop M. Kantarjian, Gautam Borthakur et al. · Blood · 2014 · 112 citations

Oral decitabine–cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study

Guillermo Garcia‐Manero, James McCloskey, Elizabeth A. Griffiths et al. · The Lancet Haematology · 2023 · 73 citations

, , +7

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

Premal Lulla, Swati Naik, Spyridoula Vasileiou et al. · Blood · 2020 · 63 citations · Full text

An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes

May Daher, Juliana Elisa Hidalgo Lopez, Jasleen K. Randhawa et al. · American Journal of Hematology · 2017 · 27 citations · Full text

Clinical Efficacy and Safety of Oral Decitabine/Cedazuridine in 133 Patients with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Michael R. Savona, James McCloskey, Elizabeth A. Griffiths et al. · Blood · 2020 · 21 citations · Full text

Rows per page

1–5 of 9